TURKISH JOURNAL OF CHEMISTRY, published by the Tubitak Scientific & Technological Research Council Turkey, serves as a significant platform for the dissemination of research in the diverse field of chemistry. Since its inception in 1996, this peer-reviewed journal has made substantial contributions to the body of knowledge within the field, currently holding a respectable Q3 ranking in the category of Chemistry (miscellaneous) as of 2023. Researchers and professionals alike rely on this journal for its wide-ranging discussions, innovative methodologies, and noteworthy findings pertinent to both fundamental and applied chemistry. With an ISSN of 1300-0527 and a commitment to promoting scientific progress, the journal is accessible to a global audience and encourages the open sharing of insights that drive advancements in chemistry. The extended timeframe of convergence until 2024 highlights the journal's dedication to fostering ongoing research and collaboration within the scientific community. As a valuable resource for researchers, professionals, and students, the Turkish Journal of Chemistry aims to inspire new discoveries and facilitate knowledge transfer in a dynamic and evolving discipline.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, published by Taylor & Francis Ltd, is a premier open-access journal that has been at the forefront of research in the field of medicinal chemistry since its inception in 1985. With an ISSN of 1475-6366 and an E-ISSN of 1475-6374, this journal boasts a prestigious reputation reflected in its impressive Q1 rankings across critical categories such as Drug Discovery and Pharmacology as of 2023. Situated in the United Kingdom, it plays a vital role in disseminating high-quality research that addresses the burgeoning needs of drug discovery and enzyme inhibition methodologies. The journal supports full open access, providing a platform for researchers, professionals, and students to share significant findings and innovations widely. With a robust impact factor, the JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY is indispensable for any academic or professional involved in the pharmacological sciences, offering an unparalleled insight into the latest advancements in therapeutic strategies and drug development.

CURRENT TOPICS IN MEDICINAL CHEMISTRY is a prestigious journal published by Bentham Science Publishers Ltd, dedicated to advancing the field of medicinal chemistry through the dissemination of high-quality research from 2001 to 2024. With an ISSN of 1568-0266 and an E-ISSN of 1873-4294, this journal is recognized for its significant contributions, as evidenced by its Scopus ranking in the 63rd percentile in the category of Drug Discovery, specifically at position #58 out of 157. Currently placed in Quartile 3 within Drug Discovery and Quartile 2 in miscellaneous medicine as of 2023, it serves as an essential resource for researchers, professionals, and students interested in the latest developments, methodologies, and applications in medicinal chemistry. The journal aims to foster collaboration and innovation by featuring original research articles, reviews, and brief communications that address current and emerging challenges in the discipline. Although it is not an open access platform, the journal's rich content is indispensable for those striving to enhance therapeutic strategies and drug development processes.

ARCHIV DER PHARMAZIE is a prestigious journal published by WILEY-V C H VERLAG GMBH, dedicated to pioneering advances in the fields of Pharmaceutical Science and Drug Discovery. With an impactful history dating back to its inception in 1822, this journal is recognized for its significant contribution to the pharmaceutical sciences, maintaining an impressive Q2 ranking in both the Drug Discovery and Pharmaceutical Science categories as of 2023. The journal’s commitment to excellence is reflected in its Scopus rankings, placing it in the top tiers of relevant fields, ensuring a broad reach and impact among researchers and professionals. Although Open Access options are not available, ARCHIV DER PHARMAZIE continues to be an invaluable resource for scholars seeking to stay abreast of cutting-edge research and developments in pharmacy and related sciences. The journal’s contributions not only serve as crucial benchmarks in research but also enhance the understanding of pharmaceutical innovations, making it essential reading for both seasoned professionals and students alike.

Medicinal Chemistry is a prestigious journal published by Bentham Science Publishers Ltd, dedicated to advancing the field of drug discovery and development. Established in 2005 with a converged publication timeframe extending to 2024, this journal serves as a vital resource for researchers and professionals interested in the intricate processes of medicinal chemistry, pharmacology, and toxicology. With an ISSN of 1573-4064 and an E-ISSN of 1875-6638, it has established a notable presence in the academic community, currently positioned in Q3 of Drug Discovery category according to the 2023 quartiles. The journal's ranking in Scopus places it at 90 out of 157 in its field, showcasing its impact and relevance, with a percentile standing of 42. Although the journal is not open access, it continues to provide insightful articles and research findings that contribute significantly to the understanding and innovation in medicinal chemistry. Based in the United Arab Emirates, Medicinal Chemistry is committed to disseminating high-quality research that shapes the future of drug formulation and therapeutic advancement.

Chemistry Letters, published by the Chemical Society of Japan, is a distinguished academic journal that focuses on pivotal developments in the field of chemistry. Since its inception in 1973, the journal has been a vital platform for the dissemination of novel research findings across various sub-disciplines, encompassing both theoretical advancements and practical applications. As a testament to its significance in the community, Chemistry Letters has achieved a Category Quartile of Q2 in the 2023 ranking for miscellaneous Chemistry journals, reflecting its respected position among peers. Although it does not offer Open Access, the journal remains accessible through institutional subscriptions, thus ensuring a wide reach for its valuable content. With an active scope ranging from general chemistry topics to specialized studies, it is ideal for researchers, professionals, and students alike who seek to contribute to and expand their knowledge within this dynamic field. The journal continuously aims to promote excellence in chemical research, facilitating dialogue and collaboration among chemists worldwide.

Current Medicinal Chemistry is a leading journal published by Bentham Science Publishers Ltd, known for its rigorous focus on the multifaceted realm of medicinal chemistry. With an ISSN of 0929-8673 and E-ISSN 1875-533X, the journal plays a crucial role in disseminating high-quality research findings that bridge the gap between chemistry and health sciences. Operating from Sharjah, United Arab Emirates, it has been a prominent scholarly resource since its inception in 1994, and is expected to continue until 2024. Current Medicinal Chemistry has earned its place in the academic community with an impressive impact factor and categorization in Q1 and Q2 quartiles across various disciplines, including Organic Chemistry, Biochemistry, Drug Discovery, and Pharmacology, highlighting its substantial contribution to these fields. Notably, it ranks 24th in Organic Chemistry and is within the 88th percentile, underscoring its appeal to researchers, professionals, and students alike who are keen on exploring cutting-edge advancements in drug design and development. Although it is not an open-access journal, it provides vital content that informs and inspires innovation in medicinal chemistry, appealing to a global audience committed to enhancing human health through scientific discovery.

European Journal of Medicinal Chemistry, a premier publication by Elsevier France-Editions Scientifiques Médicales Elsevier, has been at the forefront of advancing medicinal chemistry since its inception in 1974. With an impressive impact factor and ranking in the Q1 quartile across multiple categories including Drug Discovery, Medicine (miscellaneous), Organic Chemistry, and Pharmacology, this journal delivers cutting-edge research and reviews that are vital for researchers and professionals in the field. The journal’s scope encompasses the design, synthesis, and evaluation of biological activity of bioactive compounds, making it a critical resource for those looking to innovate in drug development and therapeutic strategies. Although currently not open access, subscribers can benefit from its diverse range of high-quality articles, ensuring the dissemination of knowledge in the ever-evolving landscape of medicinal chemistry. The European Journal of Medicinal Chemistry continues to play a pivotal role in shaping the future of pharmacological research and its application, thus appealing to an audience dedicated to making impactful scientific contributions.

MEDICINAL RESEARCH REVIEWS, published by Wiley, is a leading journal in the fields of Drug Discovery, Molecular Medicine, and Pharmacology. With an impressive impact factor and esteemed standing in its category quartiles (Q1 in all three fields), this journal serves as a vital platform for the dissemination of cutting-edge research and reviews that drive innovation in therapeutic development and molecular health sciences. Since its inception in 1981, MEDICINAL RESEARCH REVIEWS has garnered a robust readership within the scientific community, underscored by its high rankings in Scopus – where it ranks #3 in Pharmacology and #2 in Drug Discovery, placing it within the top echelons of academic influence. Researchers, professionals, and students alike benefit from its rich content and comprehensive approaches to tackling complex medicinal challenges, making it an essential resource for those invested in advancing the frontiers of biomedical research.

RUSSIAN CHEMICAL REVIEWS, published by the esteemed ND Zelinsky Institute of Organic Chemistry, RAS, stands as a prominent platform for disseminating high-quality research in the diverse field of chemistry. With an ISSN of 0036-021X and an E-ISSN of 1468-4837, this journal has earned its place in the Q1 quartile of Chemistry (miscellaneous) for 2023, reflecting its outstanding impact and rigorous peer-review process. The journal encompasses a wide array of topics within chemistry, providing critical reviews that advance understanding and foster collaboration among researchers, professionals, and students globally. With its consistent publication since 1970, RUSSIAN CHEMICAL REVIEWS not only serves as a valuable resource for the latest advancements in the field but also plays a crucial role in shaping future research directions. The journal is based in the Russian Federation, with its office located at 47 Leninsky Pr, Moscow 119991, RUSSIA. As an essential reference for those in the chemical sciences, it provides an ideal avenue for authors looking to publish impactful reviews that contribute to the broader scientific community.